`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`AMNEAL PHARMACEUTICALS LLC AND
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC,
`Petitioners,
`
`v.
`
`ALMIRALL, LLC,
`Patent Owner.
`
`_____________________
`
`Case IPR2019-00207
`Patent 9,517,219 B2
`_____________________
`
`PETITIONERS’ REQUEST FOR ORAL ARGUMENT
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`Case IPR2019-00207
`Patent 9,517,219 B2
`Pursuant to the Board’s May 10, 2019 Scheduling Order (Paper 14),
`
`Petitioners Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New
`
`York, LLC respectfully request oral argument, currently scheduled for February 7,
`
`2020. Petitioners request one hour in which to present their arguments. Under 37
`
`C.F.R. § 42.70, and without intending to waive any issue not specifically
`
`identified, Petitioners specify the following issues to be argued:
`
`1. Whether claims 1-8 are unpatentable under 35 U.S.C. § 103 over
`
`Garrett (AMN1004) and Nadau-Fourcade (AMN1005).
`
`2. Whether claims 1-8 are unpatentable under 35 U.S.C. § 103 over
`
`Garrett (AMN1004) and Bonacucina (AMN1015).
`
`3.
`
`4.
`
`5.
`
`Any issue discussed in the Board’s Institution Decision (Paper 13).
`
`Any issues raised by Patent Owner.
`
`Any issues for which the Board seeks clarification or any other issues
`
`the Board deems necessary for issuing a final written decision (e.g., any motion to
`
`exclude evidence and any motion to seal evidence).
`
`Petitioners also respectfully request access to the Board’s audio-visual
`
`equipment to display demonstrative exhibits, including a projector and screen for
`
`displaying documents from a computer.
`
`
`
`
`
`- 1 -
`
`
`
`
`
`
`
`
`
`Case IPR2019-00207
`Patent 9,517,219 B2
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`Date: December 20, 2019
`1100 New York Avenue, NW
`Washington, DC 20005
`(202) 371-2600
`
`
`
`Dennies Varughese, Pharm.D.
`Lead Counsel for Petitioners
`Registration No. 61,868
`
`
`
`
`
`- 2 -
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`
`The undersigned hereby certifies that the above-captioned “Petitioners’
`
`Request for Oral Argument” was served in its entirety on December 20, 2019, via
`
`electronic mail upon the following counsel for Patent Owner:
`
`James Trainor Elizabeth B. Hagan
`Richard J. Shea
`
`
` FENWICK & WEST LLP
`FENWICK & WEST LLP 1191 Second Avenue, 10th Floor
`902 Broadway, Suite 14 Seattle, WA 98101
`New York, NY 10010 Telephone (206) 389-4510
`Telephone (212) 430-2600 Facsimile (206)389-4511
`Facsimile (650) 938-5200 ehagan@fenwick.com
`jtrainor@fenwick.com
`rshea@fenwick.com
`
`Jennifer R. Bush
`FENWICK & WEST LLP
`801 California Street
`Mountain View, CA 94041
`Telephone (650) 988-8500
`Facsimile (650) 938-5200
`jbush@fenwick.com
`
`
`
`
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`
`
`Dennies Varughese, Pharm.D.
`Lead Counsel for Petitioners
`Registration No. 61,868
`
`
`
`
`Date: December 20, 2019
`1100 New York Avenue, NW
`Washington, DC 20005
`(202) 371-2600
`
`
`14300088_1.docx
`
`
`
`
`
`